Abstract:<p>Recent advances in structural biology and computational techniques have revealed allosteric mechanisms for an abundance of targets leading to the establishment of rational design of allosteric modulators as a new avenue for drug discovery. Considering that allostery is an intrinsic property of the protein conformational ensemble, allosteric drug design has the potential to develop into an innovative approach to modulate the dysregulation of therapeutic targets that are considered to be undruggable at their orthosteric site, explore strategic design opportunities to tackle new chemical space, or develop mutant-specific therapies to target mutations occurring far from the enzyme active site. Traditionally, allosteric drug discovery has been performed through high-throughput screening or through serendipitous discoveries; however, recent developments in structure-based and ligand-based methods have led to exciting advancements of designing bioactive allosteric ligands rationally. In this review article, we highlight the advantages and disadvantages of allosteric modulators and present structure-based and ligand-based drug design methodologies for the identification of allosteric binding sites and allosteric modulators. We also illustrate representative studies for the design allosteric modulators for proteins belonging to a wide range of protein families, also considering irreversible binding with covalent allosteric modulators. Additionally, we analyze challenges and successes in the rational design of allosteric inhibitors and activators. Finally, we present the future of rational allosteric ligand design with newly built computational tools that we expect to be applied in future studies, concluding to theoretical and practical guidelines for allosteric ligand design strategies and identify knowledge gaps that need to be addressed to improve efficiency in allosteric drug design.</p><p>This article is categorized under: </p><ul class="plain-list"><li>Structure and Mechanism > Computational Biochemistry and Biophysics</li><li>Structure and Mechanism > Molecular Structures</li></ul>

Design of an allosterically modulated doxycycline and doxorubicin drug-binding protein

De novo design of drug-binding proteins with predictable binding energy and specificity

Robust de novo design of protein binding proteins from target structural information alone

De novo design of allosterically switchable protein assemblies

Allosteric drugs: New principles and design approaches

Rational design of allosteric modulators: Challenges and successes

Toward the Design of Allosteric Effectors: Gaining Comprehensive Control of Drug Properties and Actions

Designed dualsteric modulators: A novel route for drug discovery

Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.

The value of protein allostery in rational anticancer drug design: an update

Computational elucidation of allosteric communication in proteins for allosteric drug design

Design of High Affinity Binders to Convex Protein Target Sites

De novo design of modular and tunable protein biosensors

Rational Design of Daunorubicin C-14 Hydroxylase Based on the Understanding of Its Substrate-Binding Mechanism

Maßgeschneiderte Liganden für Protein-Protein-Interaktionen

De novo design of high-affinity binders of bioactive helical peptides

Nonnatural Protein–protein Interaction-Pair Design by Key Residues Grafting

Modulating protein activity using tethered ligands with mutually exclusive binding sites

Incorporating an allosteric regulatory site in an antibody through backbone design

Computational Design Of Ligand-Binding Proteins

Engineering protein theranostics using bio-orthogonal asparaginyl peptide ligases